This Week in PNAS

In the early, online edition of the Proceedings of the National Academy of Sciences, researchers from the University of California, San Francisco, and elsewhere demonstrate the feasibility of adding in or removing specific sequences in human immune CD4+ T cells using a CRISPR/Cas9 gene editing system.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more